Stroke in 2015: the year of endovascular treatment
Author:
- 1 January 2016
- journal article
- review article
- Published by Elsevier in The Lancet Neurology
- Vol. 15 (1) , 2-3
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trialThe Lancet, 2015
- Thrombectomy within 8 Hours after Symptom Onset in Ischemic StrokeNew England Journal of Medicine, 2015
- Safety and efficacy of desmoteplase given 3–9 h after ischaemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): a double-blind, randomised, placebo-controlled phase 3 trialThe Lancet Neurology, 2015
- Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) Trial: Protocol for a Randomized, Controlled, Multicenter Study Comparing the Solitaire Revascularization Device with IV tPA with IV tPA Alone in Acute Ischemic StrokeInternational Journal of Stroke, 2015
- Randomized Assessment of Rapid Endovascular Treatment of Ischemic StrokeNew England Journal of Medicine, 2015
- Endovascular Therapy for Ischemic Stroke with Perfusion-Imaging SelectionNew England Journal of Medicine, 2015
- A Randomized Trial of Intraarterial Treatment for Acute Ischemic StrokeNew England Journal of Medicine, 2015
- Impact of centralising acute stroke services in English metropolitan areas on mortality and length of hospital stay: difference-in-differences analysisBMJ, 2014
- Treatment in a Combined Acute and Rehabilitation Stroke UnitStroke, 1999